← Back to Search

Motor Control Evaluation for Parkinson's Disease

N/A
Recruiting
Led By Hyosub Kim, PhD
Research Sponsored by University of Delaware
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Able to perform reaching movements of ~20 cm (8 inches)
Age 18-85 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during intervention
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing how well people with Parkinson's can control their reaching movements in different environments.

Who is the study for?
This trial is for people aged 18-85 with Parkinson's Disease who can make reaching movements and are on Parkinson's medication. They must have a good level of mental function (MMSE score ≥ 26/30) and be able to attend all test sessions.
What is being tested?
The study focuses on understanding motor control in Parkinson's patients by observing their responses to changes while they reach for things in virtual reality.
What are the potential side effects?
Since the intervention involves assessment rather than medication, there are no direct side effects from drugs; however, participants may experience fatigue or discomfort from the VR environment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can reach out about 8 inches.
Select...
I am between 18 and 85 years old.
Select...
I have been diagnosed with Parkinson's disease.
Select...
I am currently on medication that affects dopamine levels.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and during intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
End-point errors
Movement times
Reaction times

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Behavioral testingExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

National Institutes of Health (NIH)NIH
2,818 Previous Clinical Trials
8,161,595 Total Patients Enrolled
University of DelawareLead Sponsor
161 Previous Clinical Trials
25,401 Total Patients Enrolled
Hyosub Kim, PhDPrincipal InvestigatorUniversity of Delaware

Media Library

motor control assessment Clinical Trial Eligibility Overview. Trial Name: NCT04616508 — N/A
Parkinson's Disease Research Study Groups: Behavioral testing
Parkinson's Disease Clinical Trial 2023: motor control assessment Highlights & Side Effects. Trial Name: NCT04616508 — N/A
motor control assessment 2023 Treatment Timeline for Medical Study. Trial Name: NCT04616508 — N/A
~0 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top